Oliver Lagore Vanvalin Investment Group Astrazeneca PLC Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 13,175 shares of AZN stock, worth $848,997. This represents 0.29% of its overall portfolio holdings.
Number of Shares
13,175
Previous 11,548
14.09%
Holding current value
$848,997
Previous $900,000
14.0%
% of portfolio
0.29%
Previous 0.27%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.05 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.4 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.37 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.23 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...